Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details 2)

v3.7.0.1
Income Taxes (Details 2) - USD ($)
$ in Thousands
Jun. 30, 2017
Jun. 30, 2016
Deferred tax assets (liabilities):    
Net operating loss $ 17,827 $ 17,172
Share-based compensation 3,072 726
Research and development tax credits 1,285 1,097
Suspended losses in iBio CMO 2,762 255
Basis in iBio CMO 538 145
Intangible assets (267) (219)
Vacation accrual and other 24 17
Valuation allowance (25,241) (19,193)
Total $ 0 $ 0